簡介:Adaphostin是AG957的金剛烷酯,是一種有效的p210bcr/abl抑制劑(IC50=14μM)。阿達磷素誘導(dǎo)T淋巴細胞白血病細胞系(IC50范圍為17-216nm)凋亡。阿達磷素對慢性和急性髓系白血病細胞具有顯著的選擇性活性。阿達磷素增加了CLL B細胞內(nèi)的活性氧水平[1][2][3]。
Adaphostin物理化學性質(zhì):
密度 |
1.33g/cm3 |
沸點 |
606.2oC at 760mmHg |
分子式 |
C24H27NO4 |
分子量 |
393.475 |
閃點 |
320.4oC |
精確質(zhì)量 |
393.194 |
PSA |
70 |
LogP |
4.9913 |
蒸汽壓 |
2.73E-15mmHg at 25°C |
折射率 |
1.661 |
Adaphostin詳細介紹:
中文名稱: |
金剛烷-1-基4-[(2,5-二羥基芐基)氨基]苯甲酸酯 |
中文別名: |
金剛烷-1-基4-[(2,5-二羥基芐基)氨基]苯甲酸酯 |
英文名稱: |
Adaphostin |
英文別名: |
Benzoic acid,4-[[(2,5-dihydroxyphenyl)methyl]amino]-, tricyclo[3.3.1.13,7]dec-1-yl ester;Adaphostin;1-adamantyl 4-[(2,5-dihydroxyphenyl)methylamino]benzoate;4-[[(2,5-Dihydroxyphenyl)Methyl]aMino]benzoicacidtricyclo[3.3.1.13,7]dec-1-ylester;4'-adamantylbenzoate-1'-N-1,4-dihydroxybenzylamine;AG 957,Adamantyl Ester;tyrphostin AG957 adamantyl ester;NSC 680410 |
CAS號: |
241127-58-2 |
分子式: |
C24NO4H27 |
分子量: |
393.48 |
詳細描述 |
博飛美科提供241127-58-2,Adaphostin,Medlife,上?,F(xiàn)貨。 Medlife,致力于提供高品質(zhì)、高性價比小分子化合物的產(chǎn)品。 Medlife小分子化合物大量庫存,提供超過2萬種的抑制劑、激動劑、拮抗劑等產(chǎn)品,是藥物及疾病研究的重要原料供應(yīng)商。 P210 bcr/abl酪氨酸激酶抑制劑,Adaphostin is a novel activator of Fas-mediated death pathway in Bcr/Abl-positive leukaemia. 查詢關(guān)鍵詞:“241127-58-2,Adaphostin,PC15946,Medlife,上?,F(xiàn)貨”。 |
Adaphostin參考文獻:
[1]. Svingen PA, et al. Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro. Clin Cancer Res. 2000;6(1):237-249.
[2]. Avramis IA, et al. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines. Cancer Chemother Pharmacol. 2002;50(6):479-489.
[3]. Orsolic N, et al. Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells. Cancer Sci. 2006;97(9):952-960.
[4]. Chandra J, et al. Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells. Blood. 2003;102(13):4512-4519.
產(chǎn)品技術(shù)規(guī)格說明書由上海創(chuàng)賽科技有限公司收集整理,僅作參考使用